- Cohort results from Phase 2 ILUSTRO study evaluating a zolbetuximab triplet combination regimen in first-line advanced gastric and gastroesophageal junction (GEJ) cancer featured in late-breaking ...
Pancreatic cancer multi-center clinical trial in U.S. is underway; patient recruitment expected to be completed by the end of Q1 2026 JERUSALEM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd ...
Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Mutants exist in a world where the people in power, and most of the public honestly, wants them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback